Search Within

Sarat Chandarlapaty

  1. "2013"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  2. Breast Medicine Service (5)
  3. Department of Medicine (5)
  4. GSK Faculty (5)
  5. Human Oncology and Pathogenesis Program (5)
  6. Solid Tumor Oncology Division (5)

More Groups

People
  1. Clifford Hudis (3)
  2. Devika Gajria (2)
  3. Jose Baselga (2)
  4. Neal Rosen (2)
  5. Nicola Hamilton (2)
  6. Poulikos Poulikakos (2)

More People

Years
  1. 2013 (5)
Publications
  1. Cancer Research (2)
  2. Breast Cancer Research (1)
  3. Journal of Clinical Oncology (1)
  4. Nature Genetics (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (1)
  3. Biomed Central Ltd (1)
  4. Nature Publishing Group (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS signaling
    Meeting Abstract

    Will, M.; Toy, W.; Yao, Z.; Poulikakos, P.; Rodrik-Outmezguine, V. ; Schneider, C.; Paul, J.; Baselga, J.; Liu, N.; Rosen, N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Feedback dependent suppression of mitogenic signaling and its effect on RAF inhibition in BRAFV600E melanomas
    Meeting Abstract

    Lito, P.; Pratilas, C.; Joseph, E.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; de Stanchina, E.; Chandarlapaty, S.; Poulikakos, P.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
    Journal Article

    Hudis, C.; Swanton, C.; Janjigian, Y. Y.; Lee, R.; Sutherland, S.; Lehman, R.; Chandarlapaty, S.; Hamilton, N.; Gajria, D.; Knowles, J.; more...
    Breast Cancer Research (2013)

    Fulltext@MSK | Save
  • ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
    Journal Article

    Toy, W.; Shen, Y.; Won, H.; Green, B.; Sakr, R. A.; Will, M.; Li, Z.; Gala, K.; Fanning, S.; King, T. A.; more...
    Nature Genetics (2013)

    Fulltext@MSK | Save